Loading...

Cannara Biotech Inc.

LOVFFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$1.31
$-0.02(-1.24%)

Cannara Biotech Inc. (LOVFF) Stock Competitors & Peer Comparison

See (LOVFF) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
LOVFF$1.31-1.24%120.1M13.14$0.10N/A
MKGAF$134.65-1.72%58.5B17.69$7.61+1.86%
MKKGY$26.67-0.52%55.1B17.49$1.52+1.88%
HLNCF$4.90-0.51%44B23.33$0.21+1.78%
IPSEY$32.42-1.76%42.9B26.15$1.24+0.80%
TKPHF$27.05-8.31%42.6B60.11$0.45+4.92%
SDZNY$59.42-1.35%25.6B-2970.00-$0.02+1.14%
ESALY$61.51-2.11%17.6B20.54$3.00N/A
TEVJF$14.00+0.00%16.1B-12.17-$1.15N/A
SGIOY$8.61+0.41%14.6B12.66$0.68+1.85%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

LOVFF vs MKGAF Comparison July 2025

LOVFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LOVFF stands at 120.1M. In comparison, MKGAF has a market cap of 58.5B. Regarding current trading prices, LOVFF is priced at $1.31, while MKGAF trades at $134.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LOVFF currently has a P/E ratio of 13.14, whereas MKGAF's P/E ratio is 17.69. In terms of profitability, LOVFF's ROE is +0.15%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, LOVFF is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for LOVFF.Check MKGAF's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;